|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ionescu VA, Gheorghe G, Bacalbasa N,
Chiotoroiu AL and Diaconu C: Colorectal cancer: From risk factors
to oncogenesis. Medicina (Kaunas). 59(1646)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dohrn N and Klein MF: Colorectal cancer:
Current management and future perspectives. Br J Surg.
110:1256–1259. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hossain MS, Karuniawati H, Jairoun AA,
Urbi Z, Ooi J, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC,
et al: Colorectal cancer: A Review of carcinogenesis, global
epidemiology, current challenges, risk factors, preventive and
treatment strategies. Cancers (Basel). 14(1732)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1(15065)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Addae JK, Gani F, Fang SY, Wick EC,
Althumairi AA, Efron JE, Canner JK, Euhus DM and Schneider EB: A
comparison of trends in operative approach and postoperative
outcomes for colorectal cancer surgery. J Surg Res. 208:111–120.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Park JS, Chon HJ, Jeung HC, Shin SJ, Rha
SY, Ahn JB, Lee KY, Kim NK and Chung HC: High-risk
clinicopathological features and their predictive significance in
Korean stage II colon cancer patients. J Cancer Res Clin Oncol.
142:2051–2059. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Law WL, Ho JWC, Chan R, Au G and Chu KW:
Outcome of anterior resection for stage II rectal cancer without
radiation: The role of adjuvant chemotherapy. Dis Colon Rectum.
48:218–226. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ryu HS, Kim J, Park YR, Cho EH, Choo JM,
Kim JS, Baek SJ and Kwak JM: Recurrence patterns and risk factors
after curative resection for colorectal cancer: Insights for
postoperative surveillance strategies. Cancers (Basel).
15(5791)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Okadome K, Toiyama Y, Ohi M and Kusunoki
M: Prognostic nutritional index, tumor-infiltrating lymphocytes,
and prognosis in patients with esophageal cancer. Ann Surg.
270:e104–e105. 2019.
|
|
11
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Clavien PA, Barkun J, de Oliveira ML,
Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J,
Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of
surgical complications: Five-year experience. Ann Surg.
250:187–196. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xu W, He Y, Wang Y, Li X, Young J,
Ioannidis JPA, Dunlop MG and Theodoratou E: Risk factors and risk
prediction models for colorectal cancer metastasis and recurrence:
An umbrella review of systematic reviews and meta-analyses of
observational studies. BMC Med. 18(172)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kitano S, Inomata M, Mizusawa J, Katayama
H, Watanabe M, Yamamoto S, Ito M, Saito S, Fujii S, Konishi F, et
al: Survival outcomes following laparoscopic versus open D3
dissection for stage II or III colon cancer (JCOG0404): A phase 3,
randomised controlled trial. Lancet Gastroenterol Hepatol.
2:261–268. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sakamoto J, Ohashi Y, Hamada C, Buyse M,
Burzykowski T and Piedbois P: Meta-analysis group of the Japanese
Society For Cancer Of The Colon And Rectum; Meta-Analysis Group In
Cancer. Efficacy of oral adjuvant therapy after colorectal cancer:
5-year results from three randomized trials. J Clin Oncol.
22:484–492. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Benson AB III, Schrag D, Somerfield MR,
Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J,
McAllister P, Van Cutsem E, et al: American society of clinical
oncology recommendations on adjuvant chemotherapy for stage II
colon cancer. J Clin Oncol. 22:3408–3419. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chapuis PH, Bokey E, Chan C, Keshava A,
Rickard MJFX, Stewart P, Young CJ and Dent OF: Recurrence and
cancer-specific death after adjuvant chemotherapy for stage III
colon cancer. Colorectal Dis. 21:164–173. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lakemeyer L, Sander S, Wittau M,
Henne-Bruns D, Kornmann M and Lemke J: Diagnostic and prognostic
value of CEA and CA19-9 in colorectal cancer. Diabetes.
9(21)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Stein KB, Snyder CF, Barone BB, Yeh HC,
Peairs KS, Derr RL, Wolff AC and Brancati FL: Colorectal cancer
outcomes, recurrence, and complications in persons with and without
diabetes mellitus: A systematic review and meta-analysis. Dig Dis
Sci. 55:1839–1851. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zheng X, Ma X, Deng HY, Zha P, Zhou J,
Wang RL and Jiang R: Diabetes mellitus and survival of patients
with esophageal cancer after esophagectomy: A systematic review and
meta-analysis. Dis Esophagus. 33(doz098)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Onikanni SA, Lawal B, Bakare OS, Ajiboye
BO, Ojo OA, Farasani A, Kabrah SM, Batiha GE and Conte-Junior CA:
Cancer of the liver and its relationship with diabetes mellitus.
Technol Cancer Res Treat. 21(15330338221119743)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hsieh MC, Zhang L, Velasco-Gonzalez C, Yi
Y, Pareti LA, Trapido EJ, Chen VW and Wu XC: Impact of diabetes and
modifiable risk factors on pancreatic cancer survival in a
population-based study after adjusting for clinical factors. Cancer
Causes Control. 33:37–48. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jing C, Wang Z and Fu X: Effect of
diabetes mellitus on survival in patients with gallbladder cancer:
A systematic review and meta-analysis. BMC Cancer.
20(689)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Maskarinec G, Shvetsov YB, Conroy SM,
Haiman CA, Setiawan VW and Le Marchand L: Type 2 diabetes as a
predictor of survival among breast cancer patients: The multiethnic
cohort. Breast Cancer Res Treat. 173:637–645. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bi G, Yao G, Bian Y, Xue L, Zhang Y, Lu T
and Fan H: The effect of diabetes mellitus on prognosis of patients
with non-smallcell lung cancer: A systematic review and
meta-analysis. Ann Thorac Cardiovasc Surg. 26:1–12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Coughlin SS, Calle EE, Teras LR, Petrelli
J and Thun MJ: Diabetes mellitus as a predictor of cancer mortality
in a large cohort of US adults. Am J Epidemiol. 159:1160–1167.
2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Larsson SC, Orsini N and Wolk A: Diabetes
mellitus and risk of colorectal cancer: A meta-analysis. J Natl
Cancer Inst. 97:1679–1687. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Flegal KM, Carroll MD, Kit BK and Ogden
CL: Prevalence of obesity and trends in the distribution of body
mass index among US adults, 1999-2010. JAMA. 307:491–497.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ,
Knost JA, Pathiraja K, Langdon RB, Yao SL and Lu BD: A randomized,
phase II study of the anti-insulin-like growth factor receptor type
1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients
with advanced colorectal cancer. Cancer Med. 3:988–997.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Stolarczyk E: Adipose tissue inflammation
in obesity: A metabolic or immune response? Curr Opin Pharmacol.
37:35–40. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Haffner SM: Insulin resistance,
inflammation, and the prediabetic state. Am J Cardiol. 92:18J–26J.
2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Meyerhardt JA, Catalano PJ, Haller DG,
Mayer RJ, Macdonald JS, Benson AB III and Fuchs CS: Impact of
diabetes mellitus on outcomes in patients with colon cancer. J Clin
Oncol. 21:433–440. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Olatude A, Nigan M, Singh RK, Panwar AS,
Lasisi A, Alhumaydhi FA, Kumar VJ, Mishra AP and Sharifi-Rad J:
Cancer and diabetes: The interlinking metabolic pathways and
repurposing actions of antidiabetic drugs. Cancer Cell Int.
21(499)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. Diabetes Care.
33:1674–1685. 2010.PubMed/NCBI View Article : Google Scholar
|
